^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IMA203

    i
    Other names: IMA203, autologous TCR-engineered T cells, ACTengine IMA203, IMA 2013, IMA203 T-cell product
    Associations
    News
    Trials
    Company:
    Immatics
    Drug class:
    PRAME inhibitor
    Related drugs:
    Associations
    News
    Trials